We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 521 results
  1. Recommendations for robust and reproducible preclinical research in personalised medicine

    Background

    Personalised medicine is a medical model that aims to provide tailor-made prevention and treatment strategies for defined groups of...

    Vibeke Fosse, Emanuela Oldoni, ... Teresa Torres in BMC Medicine
    Article Open access 08 January 2023
  2. Representations of personalised medicine in family medicine: a qualitative analysis

    Background

    The promise of personalised medicine (PM) to transform healthcare has sparked great enthusiasm in the last years. Yet, its lack of...

    Marie S. Boyer, Daniel Widmer, ... Daniela Cerqui in BMC Primary Care
    Article Open access 01 March 2022
  3. A functional personalised oncology approach against metastatic colorectal cancer in matched patient derived organoids

    Globally, colorectal cancer (CRC) is the third most frequently occurring cancer. Progression on to an advanced metastatic malignancy (metCRC) is...

    Dexter Kai Hao Thng, Lissa Hooi, ... Edward Kai-Hua Chow in npj Precision Oncology
    Article Open access 27 February 2024
  4. Develo** tailored intervention strategies for implementation of stratified care to low back pain with physiotherapists in Nigeria: a Delphi study

    Background

    Stratified care approach involving use of the STarT-Back tool to optimise care for patients with low back pain is gaining widespread...

    Mishael Adje, Jost Steinhäuser, ... Sven Karstens in BMC Health Services Research
    Article Open access 09 February 2023
  5. Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised Medicine

    Objective

    The objective of this study was to develop guidance contributing to improved consistency and quality in economic evaluations of personalised...

    Heleen Vellekoop, Simone Huygens, ... Maureen Rutten-van Mölken in PharmacoEconomics
    Article Open access 16 April 2021
  6. Diabetes precision medicine: plenty of potential, pitfalls and perils but not yet ready for prime time

    Rapid advances in technology and data science have the potential to improve the precision of preventive and therapeutic interventions, and enable the...

    Simon Griffin in Diabetologia
    Article Open access 24 August 2022
  7. Stratified distribution of Th17 and Treg cells in patients with multi-stage rheumatoid arthritis

    Objective

    Rheumatoid arthritis (RA) is a typical, progressive autoimmune disease. Its occurrence and development are associated with dysregulation of...

    Rui Su, Baochen Li, ... Caihong Wang in Arthritis Research & Therapy
    Article Open access 04 April 2023
  8. Personalised rehabilitation to improve return to work in patients with persistent spinal pain syndrome type II after spinal cord stimulation implantation: a study protocol for a 12-month randomised controlled trial—the OPERA study

    Background

    For patients with therapy-refractory persistent spinal pain syndrome type II (PSPS-T2), spinal cord stimulation (SCS) may serve as an...

    Maarten Moens, Lisa Goudman, ... Ann De Smedt in Trials
    Article Open access 05 December 2022
  9. Right dose, right now: bedside, real-time, data-driven, and personalised antibiotic dosing in critically ill patients with sepsis or septic shock—a two-centre randomised clinical trial

    Background

    Adequate antibiotic dosing may improve outcomes in critically ill patients but is challenging due to altered and variable pharmacokinetics....

    Luca F. Roggeveen, Tingjie Guo, ... Paul W. G. Elbers in Critical Care
    Article Open access 05 September 2022
  10. NAVIGATOR: an Italian regional imaging biobank to promote precision medicine for oncologic patients

    NAVIGATOR is an Italian regional project boosting precision medicine in oncology with the aim of making it more predictive, preventive, and...

    Rita Borgheresi, Andrea Barucci, ... Emanuele Neri in European Radiology Experimental
    Article Open access 08 November 2022
  11. Progress to Date in Advancing Stratified Medicine in Psoriasis

    Stratified medicine is the tailoring of treatment to the individual characteristics of each patient. This is a challenging task in the context of...

    Claire Reid, Lis Cordingley, ... Christopher E. M. Griffiths in American Journal of Clinical Dermatology
    Article 30 June 2020
  12. Tools for the Economic Evaluation of Precision Medicine: A Sco** Review of Frameworks for Valuing Heterogeneity-Informed Decisions

    Background and Objective

    Precision medicine highlights the importance of exploring heterogeneity in the effectiveness and costs of interventions. Our...

    Reka E. Pataky, Stirling Bryan, ... Dean A. Regier in PharmacoEconomics
    Article 27 July 2022
  13. Pinpointing precision medicine for diabetes mellitus

    Anna Krook, Hindrik Mulder in Diabetologia
    Article 23 August 2022
  14. Engineering prostate cancer in vitro: what does it take?

    A key challenge in the clinical management and cause of treatment failure of prostate cancer (PCa) is its molecular, cellular and clinical...

    Adriana Buskin, Emma Scott, ... Anastasia C. Hepburn in Oncogene
    Article Open access 12 July 2023
  15. A pragmatic randomised controlled trial referring to a Personalised Self-management SUPport Programme (P-SUP) for persons enrolled in a disease management programme for type 2 diabetes mellitus and/or for coronary heart disease

    Background

    Type 2 diabetes mellitus (T2DM) and coronary heart disease (CHD) are two chronic diseases that cause a tremendous burden. To reduce this...

    Uwe Konerding, Marcus Redaèlli, ... Stephanie Stock in Trials
    Article Open access 27 September 2021
  16. The Interface of Therapeutics and Genomics in Cardiovascular Medicine

    Pharmacogenomics has a burgeoning role in cardiovascular medicine, from warfarin dosing to antiplatelet choice, with recent developments in...

    E. F. Magavern, J. C. Kaski, ... M. Pirmohamed in Cardiovascular Drugs and Therapy
    Article 02 February 2021
  17. Lifestyle interventions in pregnancy targeting GDM prevention: looking ahead to precision medicine

    Gestational diabetes mellitus (GDM) is the most prevalent pregnancy-related endocrinopathy, affecting up to 25% of pregnancies worldwide. Pregnant...

    Joshua R. Sparks, Nidhi Ghildayal, ... Leanne M. Redman in Diabetologia
    Article 12 February 2022
  18. Towards Personalising the Use of Biologics in Rheumatoid Arthritis: A Discrete Choice Experiment

    Introduction

    There have been promising developments in technologies and associated algorithm-based prescribing (‘stratified approach’) to target...

    Caroline M Vass, Anne Barton, Katherine Payne in The Patient - Patient-Centered Outcomes Research
    Article Open access 18 June 2021
  19. Adapting the randomised controlled trial (RCT) for precision medicine: introducing the nested-precision RCT (npRCT)

    Adaptations to the gold standard randomised controlled trial (RCT) have been introduced to decrease trial costs and avoid high sample sizes. To...

    Nils Kappelmann, Bertram Müller-Myhsok, Johannes Kopf-Beck in Trials
    Article Open access 06 January 2021
Did you find what you were looking for? Share feedback.